Skip to main content

Cipla 446 Pill - red blue capsule/oblong, 23mm

Pill with imprint Cipla 446 is Red / Blue, Capsule/Oblong and has been identified as Atazanavir Sulfate 300 mg. It is supplied by Cipla USA Inc.

Atazanavir is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 446

Atazanavir sulfate 300 mg Cipla 446
Atazanavir sulfate 300 mg Cipla 446

Atazanavir Sulfate

Imprint
Cipla 446
Strength
300 mg
Color
Red / Blue
Size
23.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0446
Inactive Ingredients
lactose monohydrate, crospovidone, magnesium stearate, gelatin, sodium lauryl sulfate, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40, D&C Yellow No. 10, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.